Market Overview

iCAD Announces First European Patients Treated with Xoft Radiation Therapy System

iCAD, Inc. (Nasdaq: ICAD) announced the first European patients have been treated with the Xoft Axxent® Electronic Brachytherapy System®. Pius-Hospital Oldenburg in Oldenburg, Germany, and Hospital CUF Porto, Portugal, are the first to use the Xoft system in Europe for treating early stage breast cancer. This announcement was made during ESTRO, the annual meeting of the European Society for Radiotherapy & Oncology, taking place May 9-13 in Barcelona, Spain, where iCAD is showcasing the Xoft system.

Posted-In: News FDA

 

Related Articles (ICAD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters